Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial

被引：0
|
作者：
Favi, E. [1 ]
Silvestrini, N. [1 ]
Salerno, M. P. [1 ]
Romagnoli, J. [1 ]
Citterio, F. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Renal Transplant Unit, Dept Surg Sci, Rome, Italy
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
55
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [41] Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study
    Gatault, P.
    Kamar, N.
    Buchler, M.
    Colosio, C.
    Bertrand, D.
    Durrbach, A.
    Albano, L.
    Rivalan, J.
    Le Meur, Y.
    Essig, M.
    Bouvier, N.
    Legendre, C.
    Moulin, B.
    Heng, A. -E.
    Weestel, P. -F.
    Sayegh, J.
    Charpentier, B.
    Rostaing, L.
    Thervet, E.
    Lebranchu, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) : 1370 - 1379
  • [42] Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
    Rostaing, Lionel
    Bunnapradist, Suphamai
    Grinyo, Josep M.
    Ciechanowski, Kazimierz
    Denny, Jason E.
    Silva, Helio Tedesco, Jr.
    Budde, Klemens
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (04) : 648 - 659
  • [43] Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
    Silva, Helio Tedesco, Jr.
    Yang, Harold C.
    Meier-Kriesche, Herwig-Ulf
    Croy, Richard
    Holman, John
    Fitzsimmons, William E.
    First, M. Roy
    TRANSPLANTATION, 2014, 97 (06) : 636 - 641
  • [44] Extended-Release Tacrolimus Therapy Is Effective and Safe in De Novo Kidney Transplant Recipients from Living and Expanded, Standard, or after Cardiac Death Deceased Donors.
    Andres, A.
    Gonzalez, E.
    Polanco, N.
    Garcia-Puente, L.
    Morales, J.
    Molina, M.
    Gutierrez-Solis, E.
    Hernandez, A.
    Sevillano, A.
    Praga, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 428 - 428
  • [45] Everolimus with reduced-exposure cyclosporine in de novo heart transplant patients: 6-month results of a multicenter, randomized trial.
    Zuckermann, A.
    Wang, S. S.
    Keogh, A.
    Ross, H.
    Frigerio, M.
    Eisen, H.
    Bara, C.
    Laufer, G.
    Cotrufo, M.
    Lena, S.
    Sips, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 443 - 443
  • [46] One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients (vol 7, pg 595, 2007)
    Silva, H. T., Jr.
    Yang, H. C.
    Abouljoud, M.
    Kuo, P. C.
    Wisemandle, K.
    Bhattacharya, P.
    Dhadda, S.
    Holman, J.
    Fitzsimmons, W.
    First, M. Roy
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) : 1682 - 1682
  • [47] Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up
    Favi, E.
    Citterio, F.
    Spagnoletti, G.
    Gargiulo, A.
    Delreno, F.
    Romagnoli, J.
    Castagneto, M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (04) : 1152 - 1155
  • [48] A PROSPECTIVE CLINICAL TRIAL COMPARING TACROLIMUS-MMF TO CYCLOSPORINE-EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS: 2 YEARS RESULTS
    Favi, Evaldo
    Citterio, Franco
    Spagnoletti, Gionata
    Gargiulo, Antonio
    Romagnoli, Jacopo
    Castagneto, Marco
    TRANSPLANT INTERNATIONAL, 2009, 22 : 241 - 241
  • [49] EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
    De Simone, P.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Duvoux, C.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3
  • [50] EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL
    Fung, J.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Nevens, F.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 4 - 4
12345